High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML

Key Points High NPM1-mutant allele burden at diagnosis is associated with poor clinical outcome in de novo AML. The adverse effect of high NPM1-mutant allele burden is independent of comutations and clinical variables.